David Altarac - Net Worth and Insider Trading

David Altarac Net Worth

The estimated net worth of David Altarac is at least $101,268 dollars as of 2024-06-21. David Altarac is the Chief Medical Officer of Entasis Therapeutics Holdings Inc and owns about 46,241 shares of Entasis Therapeutics Holdings Inc (ETTX) stock worth over $101,268. Details can be seen in David Altarac's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Altarac has not made any transactions after 2021-10-19 and currently still holds the listed stock(s).

Transaction Summary of David Altarac

To

David Altarac Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Altarac owns 1 companies in total, including Entasis Therapeutics Holdings Inc (ETTX) .

Click here to see the complete history of David Altarac’s form 4 insider trades.

Insider Ownership Summary of David Altarac

Ticker Comapny Transaction Date Type of Owner
ETTX Entasis Therapeutics Holdings Inc 2021-10-19 Chief Medical Officer

David Altarac Latest Holdings Summary

David Altarac currently owns a total of 1 stock. David Altarac owns 46,241 shares of Entasis Therapeutics Holdings Inc (ETTX) as of October 19, 2021, with a value of $101,268.

Latest Holdings of David Altarac

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ETTX Entasis Therapeutics Holdings Inc 2021-10-19 46,241 2.19 101,268

Holding Weightings of David Altarac


David Altarac Form 4 Trading Tracker

According to the SEC Form 4 filings, David Altarac has made a total of 1 transactions in Entasis Therapeutics Holdings Inc (ETTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Entasis Therapeutics Holdings Inc is the sale of 3,759 shares on October 19, 2021, which brought David Altarac around $11,991.

Insider Trading History of David Altarac

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Altarac Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Altarac Ownership Network

Ownership Network List of David Altarac

No Data

Ownership Network Relation of David Altarac

Insider Network Chart

David Altarac Owned Company Details

What does Entasis Therapeutics Holdings Inc do?

Who are the key executives at Entasis Therapeutics Holdings Inc?

David Altarac is the Chief Medical Officer of Entasis Therapeutics Holdings Inc. Other key executives at Entasis Therapeutics Holdings Inc include 10 percent owner Theravance Inc , VP & Principal Fin & Acct Off Kristie Ann Wagner , and Chief Development Officer John Patrick Mueller .

Entasis Therapeutics Holdings Inc (ETTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Entasis Therapeutics Holdings Inc (ETTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entasis Therapeutics Holdings Inc (ETTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Entasis Therapeutics Holdings Inc (ETTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Entasis Therapeutics Holdings Inc Insider Transactions

No Available Data

David Altarac Mailing Address

Above is the net worth, insider trading, and ownership report for David Altarac. You might contact David Altarac via mailing address: 35 Gatehouse Drive Waltham Ma 02451.

Discussions on David Altarac

No discussions yet.